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Comparison of multimarker logistic regression
models, with application to a genomewide
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Abstract
Background: Genome-wide association studies (GWAS) are a widely used study design for detecting genetic
causes of complex diseases. Current studies provide good coverage of common causal SNPs, but not rare ones.
A popular method to detect rare causal variants is haplotype testing. A disadvantage of this approach is that many
parameters are estimated simultaneously, which can mean a loss of power and slower fitting to large datasets.
Haplotype testing effectively tests both the allele frequencies and the linkage disequilibrium (LD) structure of the
data. LD has previously been shown to be mostly attributable to LD between adjacent SNPs. We propose a gener-
alised linear model (GLM) which models the effects of each SNP in a region as well as the statistical interactions
between adjacent pairs. This is compared to two other commonly used multimarker GLMs: one with a main-effect
parameter for each SNP; one with a parameter for each haplotype.
Results: We show the haplotype model has higher power for rare untyped causal SNPs, the main-effects model
has higher power for common untyped causal SNPs, and the proposed model generally has power in between the
two others. We show that the relative power of the three methods is dependent on the number of marker
haplotypes the causal allele is present on, which depends on the age of the mutation. Except in the case of a
common causal variant in high LD with markers, all three multimarker models are superior in power to single-SNP
tests.
Including the adjacent statistical interactions results in lower inflation in test statistics when a realistic level of
population stratification is present in a dataset.
Using the multimarker models, we analyse data from the Molecular Genetics of Schizophrenia study. The multimar-
ker models find potential associations that are not found by single-SNP tests. However, multimarker models also
require stricter control of data quality since biases can have a larger inflationary effect on multimarker test statistics
than on single-SNP test statistics.
Conclusions: Analysing a GWAS with multimarker models can yield candidate regions which may contain rare
untyped causal variants. This is useful for increasing prior odds of association in future whole-genome sequence
analyses.
Background
Genome-wide association studies (GWAS) have pro-
vided a wealth of information on associated genetic
variants for complex human diseases. To date, GWAS
have found over 2,700 new causal variants [1]. Despite
the number of variants found, significant amounts of
genetic variation remain unexplained. The remaining
variation is unlikely to be due solely to remaining unde-
tected common variants.
Maher [2] proposes several other possible causes for
the remaining variation: rare variants, copy number
variants, gene-gene interaction, and gene-environment
interaction. Rare variants are thought to be important in
many diseases, and especially so in Schizophrenia [3].
Current GWAS are generally well-powered to detect
common variants with modest effect sizes, but under-
powered to detect rare variants, even with larger effect
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sizes. Methods such as imputation can add significant
power to detect rarer variants [4], but are limited by the
size of the reference panel used. The 1000 genomes pro-
ject [5] will add significant power to detect rare variants,
but will still not reliably cover every variant with minor
allele frequency (MAF) ≤ 0.01 in the genome.
An exciting recent development is the increasing feasi-
bility of performing a full sequence analysis, which
allows the testing of every variant in the genome. Costs
have fallen several orders of magnitude in the last few
years, meaning the concept of a large scale case-control
study using the full sequences of participants will soon
be feasible.
New technology generally introduces new challenges,
and sequence analysis is no exception. The sheer num-
ber of variables in such a study will mean problems in
storage and analysis. The prior odds for a specific
variant being associated are so low that a highly signifi-
cant p-value threshold is needed to give confidence that
a seemingly statistically significant result is a true posi-
tive [6,7]. Having a set of variants with higher prior
odds before a sequence analysis begins would allow
more relaxed p-value thresholds to be applied without
resulting in large numbers of false positives. Prior odds
for association can be improved for variants within a
region with prior functional or positional evidence for
association.
Haplotype analysis has previously been proposed to
improve power to detect variants that are not typed on
a genotyping chip. Models which consider the effects of
marker haplotypes directly have been dismissed as not
being as powerful as a model which just considers the
main-effects of several nearby SNPs (referred to here as
the main-effects model) [8,9]. It has also been claimed
to take too long to apply to a genome-wide study [10],
although computational power has since increased con-
siderably. In this article, we discuss logistic regression
models which include haplotype information with differ-
ent levels of complexity in order to improve power to
detect rare variants and time taken to a large scale
GWAS. A region that shows evidence for association,
but contains no associated common variants should
have a larger prior odds for association with rare
variants.
Kim et al. [11] investigated the structure of LD and
how it can be partitioned into different orders. The
authors showed that, for individuals of European des-
cent, an average of around 65% of total LD in HapMap
ENCODE regions is attributable to LD between adjacent
SNPs. This finding led us to consider a model, inter-
mediate in complexity between the main-effects model
and haplotype testing, that would include LD informa-
tion parsimoniously. This model, denoted as the main
+adj model, includes the main-effects and statistical
interactions between adjacent SNPs. The number of
parameters is generally low compared to the haplotype
model, but should explain on average a large proportion
of the haplotype structure.
The main+adj model was considered by Humphreys
and Iles [12] amongst several other codings, and per-
formed fairly well. It was only applied to one dataset
(the GAW 14 dataset) so its strengths and weaknesses
were not thoroughly examined.
In this paper, we assess the main+adj logistic regres-
sion model, and compare it to the main-effects model
and haplotype model. We show first that for realistic
simulated data all three investigated multimarker models
provide higher power to detect untyped variants than
single-SNP tests, except in the case of a common variant
in high LD with nearby markers. We show that the
models which include more haplotype information
(main+adj and haplotype models) are more powerful
than the main-effects model for rare untyped variants
when the causal allele is on a low number of marker
haplotypes, which will be the case for more recent
mutations [13]. The main-effects model generally per-
forms best when applied to a common causal variant,
but the main+adj model does not lose much power in
this situation.
We also examine inflation in test statistics under the
null when population stratification is present. Using a
simple stratification model, we show that including the
adjacent interactions results in lower susceptibility of
bias due to population stratification. This is a desirable
property for real GWAS data with a reduced need for
methods such as principal component analysis [14] or
use of family data, which is robust to population stratifi-
cation, but has also been shown to be less cost-effective
than case-control data [15].
We then apply the models to the Molecular Genetics
of Schizophrenia GWAS of Schizophrenia [16] and
show that several regions display evidence of association
that is not shown by common variants within the same
regions. We discuss some issues with quality control
that arise from using multimarker models. Our conclu-
sion is that multimarker models can yield candidate
regions not found from imputation which may be fruit-
ful to search with a full sequence analysis.
Results and Discussion
Simulated association data
Relative performance of multimarker models
To assess the relative performance of the three multi-
marker models, we applied them to realistic simulated
data generated from COSI [17] using the supplied para-
meter values typical of European populations. For this
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section, we assume that each observation consists of one
haplotype. Later, we consider how to apply these models
when the haplotype phase is unknown.
Three different causal SNP MAFs were considered -
0.005, 0.025, and 0.25. Two different methods for
picking a causal SNP were considered, one which corre-
sponds to the causal allele being on a moderate number
of marker haplotypes, and the other corresponding to
the causal allele being on one. More details about the
simulation study are given in Methods.
Figures 1, 2 and 3 show power curves for each of the
combinations of causal SNP MAFs and causal SNP
models. Each line consists of the average power from
200 sets of six marker SNPs, each of which has the
power of detecting association estimated from 1000
simulated phenotype vectors (see methods). We grouped
sets by similar mean |r| between markers and causal
SNP. The median mean |r| value for the group and the
mean power over the grouping is plotted.
We first note that the haplotype model performs well
when the MAF of the causal SNP is low. It clearly has the
highest power for both disease models for MAF 0.005.
Additionally it performs best for the causal haplotype
case when MAF = 0.025. Previously, Chapman et al. [8]
and Clayton et al. [9] indicated that haplotype coding is
less powerful than the main-effects coding in most situa-
tions; this does not contradict our results, because that
work considered causal SNPs with MAF ≥ 0.05.
Secondly, for the disease driven by an untyped causal
SNP, adding the adjacent interactions to the main-
effects generally loses a small amount of power com-
pared to the main-effects only for MAF ≥ 0.025. For the
very rare causal SNP case, the main+adj model performs
slightly better. When the disease is associated with a
SNP on one marker haplotype, adding the adjacent
interactions gives a clear power gain for the two rare
causal SNP cases, but a small loss for the common SNP
case.
A third interesting result was the big difference
between using the multimarker tests and single-SNP
tests. The single-SNP test generally performed badly
compared to the multimarker tests. The only case in
which it provided a power boost was when the disease
was generated from a common SNP. Even in this case,
the increase in power was present only when the aver-
age |r | between markers and causal SNP was high, i.e.
almost equivalent to testing the causal SNP directly,
which is the ideal situation for single-SNP tests. We had
expected that the main+adj model would generally have
power in between the main-effects and haplotype
model, or in other words it would be a good compro-
mise model to use when the disease model is unknown.
This appears to be the case from these simulations, with
its power generally close to the power of the best
performing model.
The results are not fully generalisable to real genetic
data, because the haplotype phase was assumed to be
known and the observations were individual haplotypes
rather than haplotype pairs. Assuming that each addi-
tional causal allele contributes additively to the log-odds
of disease, this should not affect the power of the sin-
gle-SNP tests or main-effects model at all. It may affect
the power of the two higher-order models slightly, since
these are affected by haplotype uncertainty. On the
whole, we are con dent these results would show a simi-
lar pattern if applied to unphased data where the LD is
at least moderately strong, as it is for modern GWAS.
Improvement of haplotype modelling when adjacent
interactions are included
The simulation study shows that for rare causal alleles,
including the adjacent interaction terms tends to
improve power over main effects to detect a disease
which is associated with a haplotype effect. To gain
greater insight into why this is, we tested whether
including adjacent interactions significantly improved
the modelling of haplotype frequencies. As further
Figure 1 a, b - Power curves from simulation study, MAF = 0.005. Power of main-effects (red), main+adj (blue), haplotype (green), and
single-SNP tests (black) for (a) causal allele on moderate number of marker haplotypes; (b) causal allele on one marker haplotype; with causal
SNP MAF = 0.005. For details on simulation, see Methods.
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described in Methods, this was done by fitting multino-
mial logistic models with haplotype carried as the
response variable and main-effects or main+adj effects
as the explanatory variables.
We randomly chose 1000 sets of 1500 phased haplo-
type observations at six marker SNPs, with average den-
sity one SNP per approximately 5 kb, from the dataset
generated by COSI. For comparison purposes, 1000
additional sets with average density one SNP per 20 kb
were also chosen. Table 1 shows the number of marker
sets where the adjacent interactions significantly
improved the fit of the haplotype frequencies. Note that
in some sets, no adjacent interactions were included
because of high LD between markers. As expected, this
occurred less often for the sparser marker sets.
Table 1 shows that, for the vast majority of sets,
including the adjacent interactions both improves the
modelling of the haplotype frequencies significantly, and
reduces the AIC. The proportion of sets for which this
is true decreases when the marker SNPs are more
dense, but is still over 90%. This indicates that when an
untyped causal SNP is associated with a marker haplo-
type, including the adjacent interactions should improve
modelling the association between the phenotype and
genetic information. Whether or not this translates into
improving the power to detect association depends on
the number of extra parameters used by the adjacent
interactions and the level of association between causal
SNP and marker haplotype.
Population stratification
To compare the effect of population stratification on the
multimarker models, we simulated sets of 3-SNP haplo-
types from two distinct populations. The frequency of
the most common haplotype differed between popula-
tions depending on a parameter δ, with larger values of
δ yielding larger differences. The probability of an indi-
vidual from either population being a case differed
depending on a parameter μ, with larger values giving
larger differences. More details on these two parameters
are given in the Methods section. For each set of para-
meters, test statistics were calculated from 5000 inde-
pendent sets of 3000 3-SNP haplotypes. The resulting
inflation in test statistics, as measured by the ratio of
observed median test statistic to expected median test
statistic under the null, l, is shown in figure 4.
Figure 2 a, b - Power curves from simulation study, MAF = 0.025. Power of main-effects (red), main+adj (blue), haplotype (green), and
single-SNP tests (black) for (a) causal allele on moderate number of marker haplotypes; (b) causal allele on one marker haplotype; with causal
SNP MAF = 0.025.
Figure 3 a, b - Power curves from simulation study, MAF = 0.25. Power of main-effects (red), main+adj (blue), haplotype (green), and single-
SNP tests (black) for (a) causal allele on moderate number of marker haplotypes; (b) causal allele on one marker haplotype; with causal SNP
MAF = 0.25.
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Overall, the results in figure 4 appear to show that
inflation in test statistics is low when μ ≤ 0.04, but can
be high for realistic levels of population stratification
when μ is higher. This shows that care must be taken to
ensure that cases and controls are not sampled from
different populations unless the analysis allows for this.
Making judgements for individual points on figure 4 is
inadvisable, since ^ is estimated from a finite sample.
However, it is safer to look at the trend, which is consis-
tent for higher levels of population stratification (μ ≥
0.6). For the multimarker tests, the level of inflation in
statistics is highest for the main-effects model, and low-
est for the haplotype model. The main+adj model is
in-between the two, but is generally slightly closer to
the haplotype model. This is encouraging, as it shows
the main+adj model controls inflation in statistics better
than main-effects for stratified datasets.
Overall, the results show that the multimarker models
which consider higher order interaction have lower
inflation in statistics in stratified populations. We should
be more careful with significant results found using the
main-effects model, since they are more likely to be
false positives due to population stratification. Only
checking the inflation in the median may not give the
whole picture, so we also show the QQ-plots of the
statistics from the different models. These display the
quantiles of the distribution of the observed score statis-
tics against the quantiles of the theoretical distribution
under the null. Figure 5 shows the QQ-plots of the
different models for δ = 0.08, μ = 0.08, a fairly severe
level of stratification.
The dashed horizontal lines in figure 5 represent the
medians of the actual test statistics. The plots represent a
l of 1.138 for the main-effects model, 1.108 for the main
+adj omnibus model, and 1.086 for the haplotype model.
The plots in figure 5 show nothing out of the ordinary.
The level of inflation (the gradient of the line) is almost
constant until deep into the tails of the distribution.
Here, the points tend to be more divergent from the line
of constant gradient, but this is to be expected due to
sampling variance. The higher order multimarker models
are less susceptible to population stratification than the
main-effects model. This may indicate that it is the main-
effect terms which are affected by stratification, but not
the statistical interactions between SNPs. If this were the
case, then it may result in the average inflation per para-
meter to be lower for the higher order models, and there-
fore for the overall effect to be less. Another explanation
is that the simulation study assumes just one of the SNPs
is affected by stratification. If several were affected in a
window, then one might see the statistical interactions
being affected too. Thus, if SNPs affected by stratification
tended to cluster in groups, then it’s possible that the
higher order models would be more severely affected
than the main-effects model.
Although the higher order multimarker models are
less susceptible, they still show a high level of inflation.
Thus, methods for correcting for population substruc-
ture, such as EIGENSTRAT [14] should be used.
EIGENSTRAT yields principal component scores for
each individual which can be easily incorporated into
the logistic regression model.
Schizophrenia GWAS analysis
Simulated data can never fully capture the structure of
real data, so we applied the multimarker models to the
MGS study of Schizophrenia [16]. This study had geno-
typed 2,681 cases and 2,653 controls of European des-
cent using the Affymetrix 6.0 chip. Genotypes can be
obtained from the dbGaP database (www.ncbi.nlm.nih.
gov/gap/). The controls were screened members of the
general population. No genome-wide significant results
had been found using single-SNP tests, although three
SNPs showed association at p < 1 × 10-6. A region on
chromosome 6p22.1 was implicated in a subsequent
meta-analysis (described in the same paper). We used
similar quality control measures as carried out in the
actual study, which are described in the methods sec-
tion. To avoid multicolinearity problems, an LD pruning
step was used to filter out SNPs which were almost
completely inferrable from nearby SNPs. This step fil-
tered out the most SNPs, leaving 363,579 markers out
of 671,422 originally genotyped.
The methods section describes how the different
models were applied to data with unknown haplotypic
phase. We used a sliding window with fixed window
Table 1 Improvement of haplotype modelling from including adjacent interactions
Density Number of marker SNP sets with adjacent
interactions included
Number (proportion) with significant
improvement in log-likelihood
Number (proportion) with
improvement in AIC
5 727 662 (91.1%) 674 (92.7%)
20 983 955 (98.3%) 961 (97.8%)
Results of whether including adjacent interaction improves modelling of marker haplotype frequencies. Columns refer to 1) the density of marker SNPs (in terms
of 1 marker SNP per x SNPs in dataset generated by COSI); 2) the number of sets (out of 1000) where adjacent interactions were not fully predictable from main-
effects; 3) the number of sets with adjacent interactions included where they resulted in a significant improvement in model fit (at 5% significance level); 4) the
number of sets where including adjacent interactions reduced the AIC.
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size of 6 marker SNPs, since window sizes of 5-6 were
found to be most powerful for haplotype analysis by
Zaykin et al. [18].
Marginally significant results
To give a high-level comparison of results from each
model, we firstly present the number of tests on each
chromosome which had p-value 1 × 10 -4 or less.
Although this threshold is not genome-wide significant,
the number of such tests gives an indication as to
whether each method is picking up genuine associations.
Since each multimarker model is a proxy for testing
association with untyped genetic variants, comparing the
p-values from the different methods should be valid.
One issue that may cause the number of marginally
Figure 4 Inflation in test statistics from different models under population stratification. Inflation in test statistics for (a) δ = 0.02, (b) δ = 0.04,
(c) δ = 0.06, (d) δ = 0.08, (e) δ = 0.1 of main-effects (red), main+adj (blue) and haplotype (green) models. δ represents the difference between
populations of the frequency of the most common haplotype, and μ represents the difference in probabilities of a random individual from each
population being a case. Inflation is measured by l, the ratio of the median of observed statistics to the median expected under the null.
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significant p-values to not be comparable is that the
models are affected by quality control issues and stratifi-
cation differently. This is examined later.
Figure 6 shows the number of marginally significant
p-values given by each model for each chromosome. The
total numbers across the genome were 73, 111, 105, and
58 for the single-SNP tests, main-effects, main+adj, and
haplotype models respectively. These numbers show that
the main-effects and main+adj models found more signif-
icant results than the single-SNP tests. In particular, the
main-effects model performs best, with main+adj close
behind. On a chromosome level, this ranking is more
variable. For some chromosomes, the main+adj model
outperforms the main-effects model. This indicates that
the two models find different results, but also may be
consistent with sampling variance.
Significant test results do not necessarily correspond
to true positives. If we just consider the number of tests
performed (≈ 363, 500), then we’d expect an average of
just over 36 test statistics to be significant at p-value
0.0001 level by chance alone. In addition, factors such
as population stratification can cause spurious associa-
tions. To get an idea of the inflation in test statistics, we
calculated ^ from equation (12) for each model.
Figure 7 summarises ^ for each chromosome.
Figure 7 shows that the main-effects model generally
has highest ^ , followed by the main+adj model. Statis-
tics from single-SNP tests and the haplotype model
Figure 5 QQ-plots from different models under population stratification. QQ-plots showing distribution of statistics from each model
compared to the theoretical null distribution for δ = 0.08, μ = 0.08.
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generally show lower inflation; on average ^ from the
haplotype model is slightly lower. The average chromo-
some ^ across the genome for each model is 1.070,
1.101, 1.092, and 1.064 for the single-SNP, main-effects,
main+adj, and haplotype tests respectively. There are
several possible explanations for this inflation:
1. It may be due to genuine associations, since there
could be many untyped SNPs with small effect size
which are picked up by the main-effects model.
2. Population stratification can cause inflation in
multimarker test statistics, as seen earlier.
3. Problems with poor quality data may also yield
inflated test statistics.
4. If parameters in a GLM are estimated from few
observations, then the distribution of test statistics
under the null tends to be inflated.
Problems with asymptotics do not explain the pattern
of ^ seen above, since the multimarker model with
fewest parameters has the higher inflation in the med-
ian. Other quality control factors could be responsible,
but the pre-study QC step should have gone some way
to reduce false positives due to genotyping error and
HWE.
Population stratification is a plausible cause of inflated
test statistics here. The ranking of multimarker models
in terms of ^ is the same as it was for the stratification
simulation. We therefore repeated the analysis with the
top five principal components included. Test statistics
from the multimarker models became the score test for
the effects of the genetic covariates after correcting for
the principal components. Table 2 gives the genome-
wide inflation in the median test statistic for each of the
models before and after correction for stratification.
For the three multimarker models, including the prin-
cipal components significantly reduces the inflation in
the test statistics. It does not, however, completely elimi-
nate the inflation. After adjustment, the main-effects
model still has the highest inflation, with the haplotype
model having the lowest; on the other hand, the differ-
ence in ^ between the models has shrunk noticeably.
The remaining inflation may be due to one of the other
reasons above, or may be because of residual population
stratification. We included the top five principal compo-
nents, but lower ones may also be informative (though
are likely to be significantly less so).
Although we considered PC adjustment for single-
SNP tests, the type of statistic used differs. Before PC
adjustment, the Cochran-Armitage trend test was used.
Figure 6 Number of marginally significant p-values by chromosome. Number of p-values < 0.0001 for each chromosome and model.
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Adjustment of the trend test is possible, as described by
Rakovski and Stram [19]. However, currently widely
used software packages, such as PLINK [20], do not
implement this adjustment. To incorporate PCs using
PLINK, a suitable test is a 1 d.f. single-SNP logistic
regression test. Asymptotically, under the null, these
should give the same results. This does not apply when
there are biases or genuine associations present. Thus,
we do not consider the comparison here to be valid.
Since ^ has shrunk significantly, there should also be
fewer marginally significant p-values. Table 3 shows that
this is indeed the case, with 29 fewer for both main-
effects and main+adj models and 10 fewer for the
haplotype model. All models still have more significant
associations than expected under the null. Although we
have explored the marginal associations, a question of
interest is whether any highly significant associations are
present, and whether correcting for population stratifi-
cation changes this.
Although principal component approaches provide a
convenient method of adjusting test statistics for popu-
lation stratification within a logistic regression frame-
work, there have been recent publications which
propose different methods. Population stratification is
closely related to the problem of cryptic relatedness,
where the assumption of independent data is flawed due
to kinship between individuals (which is generally
greater within cases). Both population stratification and
cryptic relatedness result in hidden structure which can
cause confounding. Rakovski and Stram [19] use Gauss-
Markov estimators from a linear model where the
covariance structure is imposed to be proportional to a
relatedness matrix estimated from the data. This
Figure 7 Inflation in test statistics by chromosome. ^ for each chromosome and model.
Table 2 Inflation before and after principal component
correction
Model ^ without PC
adjustment
^ with PC
adjustment
Single-SNP
tests*
1.070 1.077
Main-effects 1.101 1.059
Main+adj 1.092 1.052
Haplotype 1.064 1.037
Comparison of inflation in median test statistics ( ^ ) for each model with and
without principal components. *Single-SNP tests without PC adjustment were
Cochran-Armitage trend statistics which are not able to incorporate PC
adjustment. The single-SNP statistics with PC adjustment are the 1 d.f. logistic
regression.
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approach is shown to have advantages over the principal
component method of EIGENSTRAT. Astle and Balding
[21] review a variety of methods, and conclude that
using linear mixed models is a powerful and computa-
tionally efficient approach which makes the most expli-
cit use of kinship. None of these techniques have been
applied to multimarker tests, and this would be an inter-
esting piece of work in its own right.
Highly significant results
Tables 4, 5 and 6 give the top 25 most significant results
for each multimarker model. Also included is the
p-value after correcting for the top five principal com-
ponents. Note that the SNP listed is the first one in the
window of 6.
The most significant p-values are generally found
using the main-effects model, followed by the main+adj
model, and lastly the haplotype model. There is also a
large overlap in which windows were most significant
from each model. The most significant test for each
model is for the 6 SNP window starting at SNP
rs7850685 on Chromosome 9. The minimum of
p-values from the single-SNP statistics for the 6 SNPs in
this window was 0.002, although 4 of the other 5 SNPs
had p-values of 0.1 or less.
There are windows for which the main+adj model is
most significant, for example the window starting at
rs1554268 on chromosome 2. The difference is not that
great before correction, and still within an order of mag-
nitude after correction for population stratification. Most
windows have more significant p-values using the main-
effects model, which may indicate that the associations
are due to common untyped SNPs rather than rare ones.
A few windows which appear in the top 25 results
from the haplotype model do not appear in either of the
Table 3 Marginally significant p-values before and after principal component correction
Model # marginally significant p-values without PC adjustment # marginally significant p-values with PC adjustment
Main-effects 111 82
Main+adj 105 76
Haplotype 58 48
Number of p-values < × 10-4 for each model with and without principal components.
Table 4 Highly significant main-effects windows
Chromosome First SNP in window Kb map location p-value PC corrected p-value
9 rs7850685 99803.7 1.36E-08 2.06E-08
9 rs10967991 27564.8 7.88E-08 8.30E-07
9 rs13049 99862.9 1.25E-07 1.57E-07
9 rs872251 99797.2 1.30E-07 2.89E-07
9 rs2783010 27571.2 4.14E-07 3.70E-06
9 rs1982915 27569.6 7.14E-07 5.60E-06
17 rs9904870 72109.7 9.59E-07 7.79E-06
9 rs10967992 27572 1.53E-06 1.49E-07
5 rs17176973 10864.5 1.86E-06 5.15E-06
5 rs13155209 10841.9 2.69E-06 2.41E-06
5 rs2964798 10841.8 2.96E-06 3.14E-06
18 rs4542737 23750.3 3.03E-06 2.18E-05
12 rs10774841 114863 3.44E-06 3.65E-06
15 rs3784405 86489 3.86E-06 9.38E-06
6 rs12211360 143162 5.15E-06 1.57E-05
6 rs197508 143139 5.18E-06 1.65E-05
5 rs17771257 10863.6 6.08E-06 1.42E-05
6 rs6928738 31039 6.35E-06 1.42E-05
2 rs1554268 22284.6 8.22E-06 1.98E-05
6 rs12205474 143141 8.72E-06 1.52E-05
1 rs12025436 80078.6 8.85E-06 1.64E-05
1 rs722589 79946.9 8.94E-06 6.65E-05
1 rs10158916 79946.2 9.13E-06 6.50E-05
2 rs12151565 22352.1 1.04E-05 8.31E-05
1 rs17422551 79964.9 1.04E-05 8.10E-05
Top 25 results by significance for main-effects omnibus tests.
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other two, for example, the window on chromosome 16
starting at rs17618203. The window is still significant
using the other two models, but the p-value is an order
of magnitude higher. It does seem that each model has
windows for which it is the most significant. This is
backed up by the simulation results earlier which
showed that in situations where the main-effects model
performed best, the other two models did still find sig-
nificant p-values for datasets which the main-effects
model did not.
Test statistics which correct for population stratifica-
tion are generally less significant than those that do not.
The level of correction differs greatly between windows.
Some, for example the window on chromosome 16
starting at rs17618203 using the haplotype test, actually
become more significant after correction; others are cor-
rected by an order of magnitude or more.
QC of top ranked windows
We examined quality control statistics for the most sig-
nificant results found. For each of the 25 most signifi-
cant main-effects omnibus tests, p-values for SNP-HWE
and differential missingness by phenotype were calcu-
lated for each SNP. Table 7 lists the minimum SNP-
HWE and differential missingness p-value, together with
the haplotype-HWE p-value for each window.
The table shows that most of the top results do not
have significant tests for any of the QC criteria. Some
results show some potential problems, for example two
of the windows on Chromosome 9 show evidence
against haplotypes being in HWE. The p-values from
testing for differential missingness may seem to be clo-
ser to 0 than they should be, but as each one is the
minimum of 6 p-values, the distribution is close to
expected under the null of no differential missingness.
The p-values for the SNP-HWE tests are more severely
away from expectation under the null of HWE, perhaps
indicating some false positives due to genotyping error.
A possible cause of false positives in haplotype testing is
when sporadic but differential genotyping error causes a
non-existent haplotype to appear in just cases (or just con-
trols). The significant deviation from haplotypic HWE in
the two consecutive windows on chromosome 9 may be
due to this type of error. We used UNPHASED [22] to
examine the haplotype distribution in cases and controls.
UNPHASED gives the case and control counts of hap-
lotypes inferred from the data, together with a p-value
Table 5 Highly significant main+adj windows
Chromosome First SNP in window Kb map location p-value PC corrected p-value
9 rs7850685 99803.7 1.84E-07 4.14E-07
9 rs10967991 27564.8 4.44E-07 7.64E-06
9 rs2783010 27571.2 1.12E-06 1.60E-05
2 rs1554268 22284.6 1.24E-06 3.98E-06
9 rs872251 99797.2 1.93E-06 5.56E-06
9 rs13049 99862.9 2.41E-06 2.88E-06
5 rs13155209 10841.9 2.59E-06 3.79E-06
17 rs9904870 72109.7 2.59E-06 1.96E-05
9 rs10967992 27572 2.96E-06 4.26E-05
9 rs1982915 27569.6 3.00E-06 3.81E-05
6 rs12211360 143162 7.46E-06 1.31E-05
1 rs12025436 80078.6 8.85E-06 1.64E-05
1 rs722589 79946.9 8.94E-06 6.65E-05
1 rs10158916 79946.2 9.13E-06 6.50E-05
12 rs10774841 114863 9.18E-06 1.26E-05
2 rs340764 16321.5 1.01E-05 1.23E-05
1 rs17422551 79964.9 1.04E-05 8.10E-05
5 rs12186813 10855.7 1.07E-05 1.85E-05
1 rs12144807 79945.4 1.09E-05 5.37E-05
6 rs10805983 74663.4 1.24E-05 5.72E-05
6 rs6928738 31039 1.38E-05 2.82E-05
22 rs178259 19654.2 1.52E-05 2.15E-05
1 rs1524183 79952.5 1.68E-05 1.03E-04
18 rs4542737 23750.3 1.75E-05 9.70E-05
22 rs178268 19660.3 1.80E-05 1.88E-05
Top 25 results by significance for main+adj omnibus tests.
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of association between phenotype and each haplotype.
Edited output for the most significant window (starting
at rs10818472) is given in table 8.
The second and third columns in table 8 show the
estimated haplotype counts in cases and controls. There
are several haplotypes which have a significant p-value.
Of these, the most significant is 2 - 2 - 1 - 4 - 3 - 1
which has estimated count 57.67 in cases and 113 in
controls. Since it is present in more controls, its esti-
mated effect is protective. There are several other haplo-
types with significant effect, one of which is present only
in controls (3 - 4 - 3 - 4 - 3 - 1). This may have resulted
from differential genotyping error. In this case, the hap-
lotype may actually not exist, but appear to due to geno-
typing errors in SNP 2. The haplotype 3 - 2 - 3 - 4 - 3 -
1 is common in both cases and controls, so even a small
chance of error per observation may result in 3 - 4 - 3 -
4 - 3 - 1 appearing in controls only and therefore
showing a significant association. On the other hand,
the significance of the window is not solely due to this
haplotype, so this doesn’t necessarily mean the result is
a false positive.
Imputation analysis of regions with highly significant
results
Several regions appear to be associated with schizophre-
nia according to our results. Two regions on Chromo-
some 9 contain many highly significant omnibus tests.
The single-SNP tests show some p-values which are sig-
nificant at 5%, but no highly significant p-values.
One of these regions is between 27564.8 kb and 27572
kb, the other is between 99797.2 kb and 99862.9 kb.
Although none of the single-SNP tests of typed SNPs in
the region shows a highly significant p-value, it is possi-
ble that an imputation analysis would find significant
associations with one or more of the untyped SNPs in
the region. Even if not, it might show many of the
untyped SNPs displaying association at a more marginal
level, which could provide evidence of a genuine asso-
ciation. With this in mind, we decided to carry out an
imputation analysis of both regions using BEAGLE [23].
BEAGLE imputes both common and rare SNPs well,
and is quick to run on large regions. We extended each
region by 50 kb in either direction to detect any nearby
associations.
Table 6 Highly significant haplotype windows
Chromosome First SNP in window Kb map location p-value PC corrected p-value
9 rs7850685 99803.7 2.14E-07 8.215372E-07
9 rs13049 99862.9 1.95E-06 1.898616E-06
22 rs178260 19654.3 7.51E-06 6.082905E-06
1 rs10158916 79946.2 8.43E-06 5.806333E-05
22 rs178259 19654.2 1.20E-05 1.794159E-05
15 rs17264145 88904.7 1.35E-05 5.959549E-05
5 rs13155209 10841.9 1.43E-05 2.769336E-05
1 rs12144807 79945.4 1.44E-05 6.107985E-05
9 rs10967991 27564.8 1.49E-05 1.232903E-04
9 rs872251 99797.2 1.60E-05 5.476211E-05
9 rs551120 134879 1.72E-05 3.428334E-05
22 rs9613019 24504.4 1.84E-05 4.384690E-06
15 rs12911150 86469.7 2.05E-05 5.855712E-05
16 rs17618203 65704.5 2.55E-05 9.370586E-06
5 rs12186813 10855.7 2.67E-05 4.666928E-05
19 rs11882629 11319.7 2.97E-05 8.237138E-05
1 rs11591084 80077.3 3.23E-05 3.804365E-05
9 rs4740559 14120.2 3.29E-05 2.475267E-05
1 rs722589 79946.9 3.49E-05 2.592247E-04
2 rs340764 16321.5 3.67E-05 5.459454E-05
9 rs3132315 136567 3.68E-05 1.894568E-05
9 rs10967992 27572 3.76E-05 4.216994E-04
1 rs17422551 79964.9 3.78E-05 2.412767E-04
7 rs16868596 88502.2 3.80E-05 5.435478E-05
12 rs1993498 10689.9 3.86E-05 5.445096E-05
Top 25 results by significance for haplotype omnibus tests.
Wason and Dudbridge BMC Genetics 2010, 11:80
http://www.biomedcentral.com/1471-2156/11/80
Page 12 of 20
As a reference panel, we used filtered HapMap phase
II release 23 data. The filtering removed SNPs with
MAF less than 0.01, and ones with genotyping rate less
than 0.95. Since HapMap phase II has a small sample
size, SNPs with a very low MAF are prone to error. We
used just the individuals of European descent, since the
MGS samples were of European descent. The reference
panel had 60 individuals genotyped at 2.3 million SNPs.
BEAGLE provides an estimate of the squared Pearson
correlation between the imputed and actual allelic
dosage. This gives an assessment of the quality of impu-
tation, with values of 0.95 or higher indicating excellent
quality imputation. We used BEAGLE to impute the
two regions of chromosome 9, using the whole of chro-
mosome 9 HapMap data as a reference panel. This
should incorporate long range LD information and
improve the quality of the imputation. Imputed SNPs
with allelic dosage squared correlations of 0.95 or
greater were tested for association with case-control sta-
tus using the 1 d.f. allelic test.
Tables S1 and S2 in additional files 1 and 2 show the
results from applying this imputation procedure to the
two aforementioned regions of chromosome 9.
The results in table S1 show that of the 41 good qual-
ity SNPs, nine have significant p-values at the 5% signifi-
cance level. Six of these were in the original dataset.
Although the minimum p-value is not near genome-
wide significance, the fact that there are a number of
marginal associations provides evidence that there may
be a genuine association within the region as a whole,
Table 7 Summary of QC statistics for most significant
windows
Chromosome SNP Min
differential
missingness
p-value
Haplotype
HWE
p-value
Min SNP
HWE
p-value
2 rs6759206 8.20E-02 4.20E-01 2.29E-01
2 rs2317011 9.86E-02 3.90E-01 2.29E-01
2 rs1962550 9.86E-02 3.90E-01 2.29E-01
5 rs2964798 4.99E-02 4.90E-01 1.57E-02
5 rs13155209 4.99E-02 7.60E-01 1.57E-02
5 rs10043680 4.86E-02 8.20E-01 2.47E-01
5 rs17771257 4.86E-02 5.80E-01 3.75E-01
5 rs17176973 4.86E-02 8.80E-01 7.01E-02
5 rs17075700 7.73E-02 3.90E-01 4.29E-02
7 rs10227362 1.16E-01 6.70E-01 3.85E-01
7 rs12534223 1.16E-01 9.30E-01 1.33E-01
9 rs10967991 1.82E-01 < 0.001 1.07E-01
9 rs1982915 1.82E-01 < 0.001 1.07E-01
9 rs2783010 1.82E-01 1.10E-02 1.07E-01
9 rs10967992 7.94E-02 1.60E-02 1.07E-01
9 rs10967993 7.94E-02 1.60E-01 1.07E-01
9 rs872251 6.24E-03 3.20E-01 7.78E-03
9 rs7850685 6.24E-03 5.00E-02 7.78E-03
9 rs13049 6.24E-03 5.70E-01 1.03E-01
10 rs682664 5.85E-02 4.70E-01 3.94E-02
12 rs10774841 3.08E-01 3.10E-01 2.40E-02
15 rs3784405 1.99E-01 6.30E-01 3.83E-01
17 rs9904870 1.88E-01 4.80E-01 2.50E-01
18 rs4542737 4.05E-02 7.60E-01 6.47E-04
20 rs967417 2.42E-01 4.30E-01 1.23E-01
QC statistics for 25 most significant main-effects windows.
Table 8 UNPHASED output
Haplotype Case Control P-value
2-2-1-2-1-1 6.115 6.69 0.2675
2-2-1-2-1-2 0.9372 0 0.308
2-2-1-2-3-1 0.6905 0 0.9992
2-2-1-4-1-1 828.9 834 0.8783
2-2-1-4-1-2 9.433 10.21 0.8322
2-2-1-4-3-1 57.67 113 3.747E-05
2-2-1-4-3-2 1.007 0 0.3188
2-2-3-2-1-1 12.98 6.27 0.3267
2-2-3-2-1-2 0 0.6707 1
2-2-3-2-3-1 1.204 0 1
2-2-3-4-1-1 0.867 1.918 0.3793
2-2-3-4-1-2 15.44 19.16 0.7131
2-2-3-4-3-1 30.39 43.74 0.2237
2-2-3-4-3-2 2.114 0.9249 0.609
2-4-1-4-1-1 1.627 3.416 0.365
2-4-3-2-1-2 0.8596 2.21 0.6195
2-4-3-4-1-1 1.591 13.85 0.002506
2-4-3-4-1-2 137.2 122.5 0.4528
2-4-3-4-3-1 0 2.456 0.01213
3-2-1-2-1-1 1.148 0.6285 0.7064
3-2-1-4-1-1 85.07 64.9 0.07011
3-2-1-4-1-2 1.305 0.2028 0.3483
3-2-1-4-3-1 3.732 0 0.3045
3-2-3-2-1-1 295.5 334.6 0.1975
3-2-3-2-1-2 7.775 4.195 0.2888
3-2-3-2-3-1 4.929 8.097 0.1492
3-2-3-4-1-1 5.902 0.8962 0.06286
3-2-3-4-1-2 48.69 19.48 0.0004034
3-2-3-4-3-1 1114 1153 0.3141
3-2-3-4-3-2 5.975 2.85 0.2993
3-4-1-4-1-1 1.055 4.961 0.1278
3-4-1-4-1-2 1.301 2.3 0.6549
3-4-1-4-3-1 1.013 0 0.3212
3-4-1-4-3-2 0 0.6906 0.09517
3-4-3-2-1-1 7.049 1.218 0.3176
3-4-3-2-1-2 12.86 31.44 0.008042
3-4-3-4-1-1 17.34 20.11 0.555
3-4-3-4-1-2 2422 2309 0.02225
3-4-3-4-3-1 0 12.7 0.004522
UNPHASED output for window beginning with SNP rs17046067.
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although the number itself means little because several
of the SNPs which show association could be in LD
with one another.
Results from table S2 are very similar. Out of 39 good
quality SNPs, 9 have p-values ≤ 0.05. Two of these were
from the original dataset, so the imputed SNPs give
more new evidence of association than the previous
region.
The results from imputation do indicate that associa-
tions within the region could be due to untyped
variants. If the imputation analysis had been performed
on the entire genome, it is unlikely that the regions
would have been picked as promising for further analy-
sis - none of the p-values are below even 1 × 10 -4. The
multimarker models on the other hand show several
highly significant windows within the region. This pro-
vides an example of how using multimarker models may
complement an imputation analysis in finding regions to
investigate further.
Summary of performance of multimarker models on
GWAS and potential for sequence analysis
Overall, the analysis of the schizophrenia GWAS shows
that multimarker tests highlight potential associations
that single-SNP tests do not. However, they also result
in more spurious associations, especially the main-
effects model.
Including the adjacent interactions reduces the infla-
tion in statistics, as was seen in simulated data
previously. It also results in fewer highly significant
p-values for this dataset. This is to be expected, since
the haplotype model performed worse than the main-
effects model and simulated data showed that the power
of the main+adj model is generally in between the
power of the other two models.
Of the most significant test results found, most appear
to be based on good quality data, with little deviation
from HWE and no evidence for differential missingness
found. This is encouraging, as it appears that the results
found uniquely through multimarker tests are not easily
dismissed as false positives. However, detailed examina-
tion of the raw genotyping data may be needed to rule
out differential genotyping error.
A next stage would be to look at regions where the
multimarker models gave results which were far more
significant than the single-SNP tests. It should be
pointed out that a lot of these significant multimarker
tests may be explained by SNPs that were filtered out by
the LD pruning step. As an example, the 6 SNP window
starting at rs9904870 on chromosome 17 actually had 8
SNPs before LD pruning. However, the two additional
SNPs in this case do not show any association with the
phenotype.
For two of the regions which multimarker tests had
indicated might be associated with schizophrenia, we
carried out an imputation analysis using BEAGLE.
Both regions contained several marginal associations,
but nothing near genome-wide significance. The impu-
tation was not optimal for detecting associations with
rare variants. For example, the reference panel used
consisted of the individuals of European descent from
HapMap phase II. This gave just 60 individuals in the
reference panel - not enough to accurately model rare
variants. The analysis would be far more accurate
when a larger reference panel, such as that currently
being developed by the 1000 genomes project, becomes
available.
All of the models used have the highest power to
detect associations when each causal allele contributes
additively to log-odds of disease. This may not be the
case, with some confirmed causal SNPs showing domi-
nance effects. In this case, the multimarker models will
lose power (as will the 1 d.f. single-SNP tests). Chapman
and Clayton [24] discuss this issue, and suggest that if
associations with such SNPs are anticipated, then an
extra parameter can be added to the logistic regression
model in order to improve the power to detect associa-
tion. This slightly reduces the power for additive causal
SNPs, but considerably improves the power for non-
additive causal SNPs.
Conclusions
In this paper we have shown that straightforward multi-
marker models have higher power than single-SNP tests
to detect rare untyped variants. The relative ranking of
models with different levels of complexity depends on
the frequency of the causal variant, and the number of
haplotypes the causal allele is present on. The best case
scenario for the haplotype model is a recent mutation
which is still rare and appears on just one marker haplo-
type. The best case scenario for the main-effects model
is a common causal allele which appears on many mar-
ker haplotypes. This would be the case when the mutant
allele appeared in the population long in the past. If, in
addition, the causal SNP is in high LD with the marker
SNPs, single-SNP tests have the highest power. The
main+adj model performs well in all situations, and is
thus a good ‘compromise model’.
We have also shown that including the adjacent inter-
actions results in lower inflation in test statistics due to
population stratification. A possible reason is that the
stratification manifests as a common-effect, and thus is
better modelled by the main-effects model.
When applied to the schizophrenia GWAS, several
regions were found which had highly significant multi-
marker test statistics, but did not contain any SNPs
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which had significant test statistics when considered
alone. This should not be taken as saying these regions
are definitely associated, but instead as illustrations of
the kind of regions which could later be analysed with a
full sequence analysis with a higher prior odds for
association.
A good candidate for a sequence analysis would be a
region that shows: 1) highly significant associations with
multimarker methods; 2) No obvious quality control
problems; 3) No single-SNP tests with marginally signifi-
cant p-value; and 4) No highly significant imputation
results.
Although the main-effects model performed best on
the schizophrenia GWAS, it may be that more samples
are needed in order to have power to detect the rare
untyped variants which the main+adj model detects
with higher power. Perhaps comparing the three multi-
marker models on a larger study may show different
results.
Overall, we have shown that multimarker logistic
regression provides a straightforward and useful comple-
ment to single-SNP analysis. Applying it to existing
GWAS data may provide new candidate regions with
highly penetrant rare causal alleles which explain more
of the heritability in complex human diseases.
Methods
Multimarker models
Logistic regression provides a flexible method of model-
ling the probability of an individual being a case as a
function of genetic and non genetic factors. For n
phased haplotypes at m SNPs, let Xij (i Î {1,...,n} j Î
{1,...,m}) be defined as:
Xij =
=
1
0
 if observation i carries the minor allele at SNP j
 if observation i carries the major allele at SNP .j
(1)
and Zij (i Î {1,...,n} j Î {1,...,h}) be defined as:
Zij =
=
1
0
 if observation i carries haplotype j
 if observation i does not carry haplotype j,
(2)
where h is the total number of haplotypes.
Using the notation given in (1) and (2), with Yi the
phenotype of the ith observation, the main-effects
model is:
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and the main+adj model is:
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In practice, we include an adjacent interaction term
only if the LD between the two SNPs is below a threshold
value. Let π11, π12, π21, π22 represent the frequencies for
the four possible phased haplotypes at two adjacent mar-
kers. Since these frequencies sum to 1, there are three
identifiable parameters modelling the effect of the two-
SNP haplotype on disease risk: the main-effects bj and
bj+1 model two of them, and the adjacent interaction
bj+m models the third. If the two SNPs are in complete
LD (D’ = 1), then at least one of the cell frequencies is 0,
and there are at most two identifiable parameters. If the
two SNPs are close to D’ = 1, then the third parameter is
identifiable, but is estimated from few observations.
According to Peduzzi et al. [25], logistic regression
experiences problems with asymptotics if fewer than ten
observations are used for estimating a parameter. Thus,
we include an adjacent interaction in the model if the
observed count of the rarest 2-SNP haplotype is ≥ 10.
Similarly for the haplotype model, we only include a
haplotype parameter if it has at least ten observations.
This is to avoid the problem of haplotype parameters
being estimated from too few observations, and assumes
that very rare haplotypes contribute negligible power to
detect a causal variant. The remaining haplotypes are
merged into one ‘rare haplotype’ category, with a para-
meter estimated for the effect of an individual carrying
one of these. This is a straightforward, and indeed, sim-
plistic method of dealing with rare haplotypes. Other
methods have been proposed [26-29] which use inferred
population histories to merge haplotypes which are
likely to have similar effects. For window sizes of six or
less dense markers, there will typically be few rare hap-
lotypes, so merging them together should not be signifi-
cantly less powerful than a more complicated method.
For large GWAS, a haplotype with ten observations or
less is extremely rare, and there is very low power to
detect a significant association with it.
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Generally, each observation is an individual with two
haplotype strands. If the haplotypic phase is known,
then each row of the design matrices in models 3 - 5
consists of the sum of the codings from the individual
haplotype strands. For instance, if individual i carries
two copies of haplotype k, then Zik = 2 in the haplotype
model. If the haplotypic phase is unknown, different
approaches may be used and are discussed later on.
For the purposes of this paper the omnibus test, of all
non-intercept parameters being 0 against the alternative
of at least one non-intercept parameter being 0, is of
interest. When the observed data is in phased format,
the likelihood ratio test can be used to assess
significance.
Simulation study
We used COSI [17] to simulate 20,000 phased haplotype
observations of a 1 Mb chromosome segment. COSI
allows the user to simulate realistic data using specified
population genetics parameters. We used the default set
of parameters which produces data with allele frequen-
cies and LD consistent with individuals of European
descent. The resulting dataset had 4,164 mutation sites,
or one every 240 bp. Many of these mutations were per-
fectly correlated with nearby mutations. After removing
these, we were left with 2,474 mutations, 955 of which
had MAF ≥ 0.05.
Parameters that were varied in the simulation study
include the MAF of the causal SNP, the density of the
marker SNPs, and the relative risk of the risk allele at
the causal locus. We considered two approaches to pick-
ing a causal SNP. These are:
1. The causal SNP is picked at random from the set
of all COSI-generated SNPs such that it has the
required MAF. Marker SNPs are sampled from the
set of nearby SNPs with MAF ≥ 0.05 such that they
have the required density. The causal SNP is not
included as a marker SNP, but is located in the mid-
dle of them.
2. A set of marker SNPs is picked from the COSI-
generated dataset with the required density. The
observed frequencies of all the distinct marker hap-
lotypes are calculated, and the marker haplotype
with frequency closest to the required causal SNP
MAF is picked. Observations that carry this marker
haplotype are assigned the causal allele, with other
observations being assigned the non-causal allele.
In the first case, the causal allele is generally on a
moderate number of marker haplotypes, whereas in the
second case it is on just one. The two situations corre-
spond to different ages of the causal mutation, with the
latter case resulting in the founder haplotype being
present only in its original form, without recombination
or mutation, i.e. the causal mutation arising recently.
Testing a large number of SNPs together is impracti-
cal in terms of time taken to fit the model, asymptotics
of the model (i.e. not enough observations per para-
meter), and power (degrees of freedom of the test statis-
tic being too large). For the simulation study we looked
at sets of six marker SNPs, which has been suggested
previously as being close to optimal for haplotype test-
ing [18].
For each replicate, a disease is generated for all obser-
vations in the COSI dataset from the causal SNP.
Observations with the non-causal allele have a baseline
risk of disease, and observations with the causal allele
have an increased risk. For each causal SNP MAF, the
relative risk was chosen to give 80% power to detect the
causal SNP directly using a 2 d.f. genotype test. A sam-
ple of 1500 case haplotypes and 1500 control haplotypes
are taken as the dataset for that replicate. This process
simulates a case-control study design.
For each dataset, four models were fitted:
1. Main-effects model from equation (3).
2. Main+adj model from equation (5).
3. Haplotype model from equation (4).
4. Logistic regression of phenotype on each SNP
individually (asymptotically equivalent to a 1 d.f.
allelic trend test). The minimum p-value from these
tests was used
The aim of the simulation study was to compare the
power of the four models for different causal SNP fre-
quencies; different LD levels between causal SNP and
marker SNPs; and different relations between the causal
allele and marker haplotypes. We considered very rare,
semi-rare, and common causal alleles with MAFs 0.005,
0.025, and 0.25 respectively. The LD between causal
SNP and marker SNP was varied by taking different
densities for the sets of marker SNPs. The possible den-
sities were one marker per 5, 10, or 20 SNPs in the
COSI dataset. These densities correspond to an average
of roughly one SNP every 5 kb, 10 kb and 20 kb
respectively.
To estimate the power we generated 1000 case-control
studies using the causal SNP and specified relative risk.
To control the type I error at 5%, we also generated
1000 independent sets of phenotype observations (the
vector Y in (3)-(5)) under the null hypothesis of no asso-
ciation for each dataset. A p-value for association for
each model was found using the likelihood ratio test.
The p-values from the null datasets gave an empirical
null distribution, from which the 5% quantile could be
used to control the type I error at 5%. The proportion
of p-values from the 1000 non-null case-control studies
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below the 5% empirical null p-value threshold gives an
estimate of power for each method.
We repeated this process a number of times for each
combination of causal SNP MAF, density, and disease
model. We grouped together results for simulated data-
sets with the same causal SNP MAF and similar mean
|r| between marker SNPs and causal SNP values, calcu-
lating the mean of the power estimates for each
grouping.
Haplotype modelling
To test whether including the adjacent interaction terms
improved the modelling of which haplotypes were car-
ried by different individuals, we fitted multinomial logis-
tic models. For a specific set of marker SNPs, let
haplotypes 1,..., h be the unique haplotypes observed,
with p1,...,ph the associated haplotype frequencies, and
n1,...,nh the number of each observed in the dataset. The
observed haplotypes can be regarded as a categorical
random variable, with the multinomial log-likelihood for
the haplotype frequencies being (up to an additive con-
stant):
n pi i
i
h
log .( )
=
∑
1
(6)
The multinomial logistic model specifies the first hap-
lotype as the reference haplotype, and models the fre-
quencies of the remaining haplotypes in relation to the
first:
log
p
p
xi i
T
1
⎛
⎝
⎜
⎞
⎠
⎟ =   i = ,. . . ,h,2 (7)
where xi
T is the ith row of the design matrix corre-
spofinding to haplotype i, and b is a set of parameters
to be estimated.
p1 is set to be
1
1 2+ =∑ ( )expjh x jT , with pi being
exp( )
exp
xi
T
j
h x j
T

1 2+ =∑ ( ) .
This constrains (p1...,ph) to be a probability distribu-
tion. After maximizing the log-likelihood under the
main-effects model and main+adj model, we tested the
improvement of fit using the likelihood ratio test. Under
the null hypothesis that the main-effects alone deter-
mine the haplotype frequencies, the likelihood ratio sta-
tistic is distributed asymptotically as a  p2 random
variable, where p is the number of adjacent interactions
included. If the haplotype frequencies are not solely
determined by the main-effects, the likelihood ratio sta-
tistic will tend to be higher. As an alternative measure
of parsimony, we also calculate the reduction in the
Akaike information criterion (AIC).
Applying to unphased data
Applying the multimarker models to unphased data
requires us to use an adjusted model which fits
directly, or to infer the underlying phased data and
apply the model to that, adjusting for uncertainty in
the haplotype distribution. Using the latter approach,
adjustment is not needed for the main-effects model,
since uncertainty in the haplotype distribution makes
no difference to the main-effects. For the main+adj
and haplotype models, we used expectation-substitu-
tion (ES). For each individual, estimated probabilities
of different haplotype pairs are found (using a haplo-
type phasing method, e.g. the EM algorithm), and the
resulting design matrix row for each possible haplotype
pair found. The design matrix row used in the GLM is
the expectation over the distribution of possible haplo-
type pairs.
ES makes several assumptions, as described in Stram
et al. [30]. All the assumptions are satisfied if the geno-
type information alone determines the haplotype distri-
bution (as opposed to the genotype and phenotype).
This is valid under the null hypothesis of no association.
ES has been assessed for correct type I error and bias
and found to perform as well as more computationally
intensive methods such as multiple imputation or a full
likelihood approach [31,32].
We have previously compared the ES approach using
estimates of phased haplotype frequencies from a
straightforward EM approach [33] with estimates from
the more sophisticated Beagle package [23]. Using
phased haplotype estimates from Beagle made little or
no difference to either the type I error rate or power of
any of the multimarker models for the MGS dataset
(unpublished data). This is despite the improvement in
phasing accuracy.
As mentioned above, we used the likelihood-ratio test
to assess significance when the data was in phased for-
mat. Kent [34] considers the distribution of the LR sta-
tistic under model mis-specification. In that case, the
distribution of the LR statistic under the null is equiva-
lent to:
 i i
i
p
Z 2
1=
∑ (8)
where Zi are independent N(0,1) random variables,
and μi i Î {1,...,p}are the eigenvalues of the matrix H
-1J.
Here, J is the covariance of the score vector, and H is
the expected score derivative matrix:
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J U y U y f y dy
T   ( ) = ( ) ( ) ( )∫ ; ; ; (9)
H
U y
T
f y dy= −
∂ ( )
∂
( )∫ ; ; ,  (10)
Where θ are the parameters of the model being
assessed, f(y; θ) is the likelihood function, and U(y; θ) is
the score vector, the vector of partial derivatives of f
with respect to each entry of θ.
Assuming the haplotype frequencies are correct, and
the model is correctly specified and satisfies certain reg-
ularity conditions, (H -1J) = I, and so the LR statistic is
asymptotically distributed as  p2 under the null. If the
haplotype frequencies are incorrect, it is likely that the
distribution will deviate from  p2 .
Kent [34] proposes alternative forms of the score and
Wald statistics which have the correct asymptotic distri-
bution under the null (i.e.  p2 instead of that given in
(8)), even if the model is misspecified. There is no
robust version of the likelihood-ratio statistic, but a
robust version of the score statistic is:
S U J UT= ( ) ( ) ( )−  0 0 01 (11)
Under the null, phenotype information gives no
information about the haplotype distribution, so the
expected score over the inferred haplotype distribution
can be used instead of U above. In addition, since we
are considering a binomial distribution for the pheno-
type, which is an exponential family, the covariance of
the score is equivalent to the Fisher information. This
implies that the score test as proposed by Rao [35] is
robust to model mis-specification (e.g. errors in
inferred haplotype distribution), whereas the LR test is
not. Thus, for analysing unphased data using the
ES approach, we used the score test instead of the
LR test.
If one or more of the SNPs are completely determined
by a linear function of the other SNPs, the generalised
inverse must be used in the score statistic. Calculating
the generalised inverse of a matrix requires more com-
putation than the inverse. An alternative is to remove
SNPs from the dataset which are determined from
nearby SNPs. This does not lose much information,
since the dropped SNPs are determined from the
retained SNPs, but allows quicker analysis.
All of the results in this paper assume a case-control
study design. Although this design is by far the most
common for modern GWAS, family-based designs are
still used. Cordell and Clayton [36] provide an excellent
discussion of applying logistic regression models to
family-based designs.
Population stratification simulation
For the population stratification simulation, we consid-
ered data consisting of seven possible 3-SNP haplotypes
for individuals from one of two populations. In the first
population, the most common haplotype had underlying
frequency 0.3 + δ, and the next most common had fre-
quency 0.3 - δ. In the second population, both had fre-
quency 0.3. The other five haplotypes had the same
frequency in both populations, which ranged between
0.05 and 0.15. We took δ Î {0.02, 0.04, 0.06, 0.08, 0.1}.
The haplotypes were chosen so that the first SNP dis-
played population stratification, but not the other two.
Wright’s statistic, FST , is used as a measure of the
genetic distance between populations. We estimated FST
by assuming that the allele frequencies of SNP 1 in the
two subpopulations followed the Balding-Nichols model
[37]. In that case, the variance of the subpopulation’s
allele frequencies would be p(1 - p)FST , where p is the
background allele frequency; we calculated the actual
variance, and then estimated FST as the ratio of actual
variance to p(1- p). According to Cavalli-Sforza et al.
[38], a FST of 0.01 is equivalent to divergence between
different European populations. Table 9 gives estimates
of FST for SNP 1, for each value of δ.
Each individual was a case with probability 0.5 + μ if
from the first population, 0.5 - μ if from the second. We
took μ Î {0.02, 0.04, 0.06, 0.08, 0.1}. This process pro-
duced data where the disease is not actually associated
with any of the 3 SNPs, but may appear to be due to
population stratification.
For each combination of δ and μ, we simulated 5,000
datasets. Each dataset contained 1,000 haplotypes from
population 1, and 1,000 from population 2. The haplo-
types were paired randomly within populations to form
unphased genotypes, and the individuals were assigned
case/control status randomly according to their popula-
tion. We then calculated the score statistic for associa-
tion for the main-effects, main+adj, and haplotype
omnibus models.
To assess the inflation in the distribution of test statis-
tics, we calculated ^ , a generalised version of the gen-
ome inflation factor from Devlin and Roeder [39]:
^ = Median of observed test statistics
Median of expected test statistics under null of no association
(12)
^ gives an idea of the inflation in the median of a
distribution, but for interpretations beyond this, may
not be comparable between models with different
degrees of freedom.
Quality control used in MGS GWAS
Quality control (QC) is extremely important for redu-
cing biases in an analysis of a GWAS [10,40]. The
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paper summarising the results from the WTCCC study
provides a useful summary of quality control measures
that were used in the study [41]. Some biases are
potentially more severe when analysing markers
together such as in a multimarker model approach.
One example is differential genotyping error, discussed
by Clayton et al. [42], in which genotyping errors for a
particular SNP occur at different rates in case and con-
trols. Although this can impact a single-SNP analysis,
it has the potential to be more severe in a multimarker
analysis. If a particular SNP is affected by genotyping
error, it can lead to a new haplotype being inferred
from the data which actually does not exist. If the gen-
otyping error differs between cases and controls, the
spurious haplotype may appear just in cases, or just in
controls. This may lead to the new haplotype appear-
ing to be highly associated with phenotype, and thus a
false positive result.
Generally, as in a single-SNP analysis, the best
approach to use is to attempt to filter out as much low
quality data before the analysis whilst keeping data
which may be the result of a true association. Most QC
checks use straightforward statistics or statistical tests,
such as missing data per individual, missing data per
SNP, whether a SNP deviates significantly from HWE,
whether missingness at a SNP depends on the pheno-
type, etc. There is a limit as to what can be done before
the study, however. Some tests are too computationally
intensive to be performed on large numbers of SNPs.
An example of this would be testing whether haplotypes
are in HWE.
A second problem with pre-study QC for a GWAS is
the significance threshold to use for p-values. Many
tests will have p-values of < 0.05 by chance, even if they
are from high quality data. Setting a very strict p-value
threshold (e.g. 0.05) will mean many SNPs, and poten-
tially some causal variants, will be filtered out; setting a
relaxed threshold may cause more false positives to
appear in the analysis.
One way to overcome this is to examine the distribu-
tion of QC test statistics in the most significant tests for
disease association. If the distribution in the top results
is significantly different to that expected under the
null of no association, we should be concerned. If a
particular multimarker association statistic is highly sig-
nificant, but contains several SNPs which were close to
failing the pre-study QC check, it may be appropriate to
dismiss the apparent significant result as being a false
positive.
In addition to the QC filters used in the MGS study,
we applied further steps:
• Exclude SNPs which have more than 3% missing
data. This is a stricter threshold than the 5% level
used in the MGS study, and reflects that multimar-
ker analysis may be more severely affected by miss-
ing data than single-SNP analysis.
• Exclude SNPs for which missing data rates are
significantly different in cases and controls (p-value
< 0.0001).
• Filter out SNPs which are almost completely deter-
mined by nearby SNPs. This is equivalent to taking
a tag set of SNPs, and can be done in PLINK [20]
using the -indep command.
In addition, the windows with most significant asso-
ciation statistics were tested for haplotype-HWE by
using the approach given for multi-allele SNPs in Weir
[43].
An alternative to pruning SNPs in high LD with sur-
roufinding SNPs is to t the multimarker models to every
window, but use the generalised inverse instead of the
standard inverse. Although this approach is valid, it
takes longer because: 1) the generalised inverse takes
longer to calculate than the standard inverse; and 2)
many more windows must be tested. Because we are
interested in regions that show association with multi-
marker models, analysing a sparser dataset loses little of
the information, and takes a significantly lower amount
of computation to do.
Additional material
Additional file 1: Imputation results (1). Imputation results from first
chromosome 9 region.
Additional file 2: Imputation results (2). Imputation results from
second chromosome 9 region.
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